المؤلفون: Michiko Yamashita, Yoshiaki Kamei, Akari Murakami, Erina Ozaki, Kumiko Okujima, Kana Takemoto, Megumi Takaoka, Daiki Tsukamoto, Erina Kusakabe, Tomoyuki Shidahara, Haruna Noda, Reina Aoki, Kana Taguchi, Kanako Nishiyama, Mariko Eguchi, Yasutsugu Takada

المصدر: Hereditary Cancer in Clinical Practice, Vol 19, Iss 1, Pp 1-5 (2021)

مصطلحات موضوعية: Chondroid metaplasia, BRCA1 mutation, Triple-negative breast cancer, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282, Genetics, QH426-470

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/1897-4287Test

الوصول الحر: https://doaj.org/article/8805da2c65e44a08b0bbc29a48c0e055Test

المؤلفون: Daiki Tsukamoto, Mariko Eguchi, Akari Murakami, Erina Ozaki, Kana Taguchi, Kanako Nishiyama, Tomoyuki Shidahara, Michiko Yamashita, Yasutsugu Takada, Haruna Noda, Kumiko Okujima, Erina Kusakabe, Kana Takemoto, Megumi Takaoka, Yoshiaki Kamei, Reina Aoki

المصدر: Hereditary Cancer in Clinical Practice, Vol 19, Iss 1, Pp 1-5 (2021)
Hereditary Cancer in Clinical Practice

مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, lcsh:QH426-470, Metaplastic carcinoma, Sentinel lymph node, Case Report, lcsh:RC254-282, 03 medical and health sciences, 0302 clinical medicine, Breast cancer, BRCA1 mutation, Triple-negative breast cancer, Chondroid metaplasia, Internal medicine, medicine, Adjuvant therapy, skin and connective tissue diseases, Genetics (clinical), business.industry, Cancer, Metaplastic Breast Carcinoma, medicine.disease, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, lcsh:Genetics, 030104 developmental biology, 030220 oncology & carcinogenesis, business, Ovarian cancer

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::668646b7fab7c2f2e26a05c966f4b5c5Test
https://doaj.org/article/8805da2c65e44a08b0bbc29a48c0e055Test

المؤلفون: Bignon, Lucie, Fricker, Jean-Pierre, Noguès, Catherine, Mouret-Fourme, Emmanuelle, Stoppa-Lyonnet, Dominique, Caron, Olivier, Lortholary, Alain, Faivre, Laurence, Lasset, Christine, Mari, Veronique, Gesta, Paul, Gladieff, Laurence, Hamimi, Akila, Petit, Thierry, Velten, Michel

المساهمون: Département de médecine oncologique, Centre Paul Strauss (CRLCC Paul Strauss), UNICANCER-UNICANCER, CRLCC René Huguenin (CRLCC René Huguenin), Hôpital René Huguenin Saint-Cloud, Institut Curie - Saint Cloud (ICSC)-Institut Curie - Saint Cloud (ICSC)-UNICANCER, Département de Biologie des Tumeurs, Institut Curie Paris, Unité de génétique et biologie des cancers (U830), Université Paris Descartes - Paris 5 (UPD5)-Institut Curie Paris -Institut National de la Santé et de la Recherche Médicale (INSERM), Université Paris Descartes - Paris 5 (UPD5), Université Sorbonne Paris Cité (USPC), Département de médecine oncologique Gustave Roussy, Institut Gustave Roussy (IGR), Centre Catherine-de-Sienne Nantes (CCS), Centre Régional de Lutte contre le cancer Georges-François Leclerc Dijon (UNICANCER/CRLCC-CGFL), UNICANCER, Centre de génétique - Centre de référence des maladies rares, anomalies du développement et syndromes malformatifs (CHU de Dijon), Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), Centre Léon Bérard Lyon, Centre de Lutte contre le Cancer Antoine Lacassagne Nice (UNICANCER/CAL), UNICANCER-Université Côte d'Azur (UniCA), Centre Hospitalier Georges Renon Niort (CH Georges Renon Niort), Institut Claudius Regaud, Institut Curie - Saint Cloud (ICSC), Département d'Oncologie et Hématologie Strasbourg, Les Hôpitaux Universitaires de Strasbourg (HUS), Progression tumorale et microenvironnement. Approches translationnelles et épidémiologie, UNICANCER-UNICANCER-Université de Strasbourg (UNISTRA)-Les Hôpitaux Universitaires de Strasbourg (HUS)-Centre Hospitalier Universitaire Strasbourg (CHU Strasbourg), Les Hôpitaux Universitaires de Strasbourg (HUS)-Institut Régional du Cancer

المصدر: The Breast Journal ; https://u-bourgogne.hal.science/hal-01960320Test ; The Breast Journal, 2018, 24 (3), pp.269-277. ⟨10.1111/tbj.12887⟩ ; https://onlinelibrary.wiley.com/doi/abs/10.1111/tbj.12887Test

مصطلحات موضوعية: BRCA2 mutation, neo-adjuvant chemotherapy, pathologic complete response, prognostic significance, triple-negative breast cancer, BRCA1 mutation, [SDV.CAN]Life Sciences [q-bio]/Cancer

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/28929593; hal-01960320; https://u-bourgogne.hal.science/hal-01960320Test; PUBMED: 28929593

الإتاحة: https://doi.org/10.1111/tbj.12887Test
https://u-bourgogne.hal.science/hal-01960320Test

المؤلفون: Véronique Mari, Catherine Noguès, Paul Gesta, Laurence Faivre, Thierry Petit, Jean-Pierre Fricker, Christine Lasset, Michel Velten, Emmanuelle Mouret-Fourme, Lucie Bignon, Alain Lortholary, Akila Hamimi, Laurence Gladieff, Olivier Caron, Dominique Stoppa-Lyonnet

المساهمون: Département de médecine oncologique, CRLCC Paul Strauss, CRLCC René Huguenin, Département de Biologie des Tumeurs, Institut Curie [Paris], Unité de génétique et biologie des cancers (U830), Université Paris Descartes - Paris 5 (UPD5)-Institut Curie [Paris]-Institut National de la Santé et de la Recherche Médicale (INSERM), Université Paris Descartes - Paris 5 (UPD5), Université Sorbonne Paris Cité (USPC), Département de médecine oncologique [Gustave Roussy], Institut Gustave Roussy (IGR), Centre Catherine-de-Sienne [Nantes] (CCS), Centre Régional de Lutte contre le cancer Georges-François Leclerc [Dijon] (UNICANCER/CRLCC-CGFL), UNICANCER, Centre de génétique - Centre de référence des maladies rares, anomalies du développement et syndromes malformatifs (CHU de Dijon), Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), Centre Léon Bérard [Lyon], Centre de Lutte contre le Cancer Antoine Lacassagne [Nice] (UNICANCER/CAL), UNICANCER-Université Côte d'Azur (UCA), Centre Hospitalier Georges Renon [Niort] (CH Georges Renon Niort), Institut Claudius Regaud, Hôpital René HUGUENIN (Saint-Cloud), Département d'Oncologie et Hématologie [Strasbourg], Les Hôpitaux Universitaires de Strasbourg (HUS), Progression tumorale et microenvironnement. Approches translationnelles et épidémiologie, Université de Strasbourg (UNISTRA)-CHU Strasbourg-Les Hôpitaux Universitaires de Strasbourg (HUS)-Institut Régional du Cancer-Centre Paul Strauss : Centre Régional de Lutte contre le Cancer (CRLCC), université de Bourgogne, LNC, Institut Curie [Paris]-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Descartes - Paris 5 (UPD5), Institut Curie, Université Paris Descartes - Paris 5 (UPD5)-Institut Curie-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Régional de Lutte contre le cancer - Centre Georges-François Leclerc (CRLCC - CGFL), Centre Antoine Lacassagne, CRLCC Antoine Lacassagne, CRLCC Institut Claudius Regaud

المصدر: The Breast Journal
The Breast Journal, 2018, 24 (3), pp.269-277. ⟨10.1111/tbj.12887⟩

مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_treatment, neo-adjuvant chemotherapy, BRCA2 mutation, Triple Negative Breast Neoplasms, Docetaxel, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Anthracyclines, skin and connective tissue diseases, Triple-negative breast cancer, BRCA1 Protein, Middle Aged, Neoadjuvant Therapy, 3. Good health, prognostic significance, Treatment Outcome, 030220 oncology & carcinogenesis, Mutation (genetic algorithm), triple-negative breast cancer, Female, Adult, Heterozygote, medicine.medical_specialty, Paclitaxel, Anthracycline, [SDV.CAN]Life Sciences [q-bio]/Cancer, Disease-Free Survival, 03 medical and health sciences, pathologic complete response, Breast cancer, BRCA1 mutation, [SDV.CAN] Life Sciences [q-bio]/Cancer, Internal medicine, Internal Medicine, medicine, Humans, Neo adjuvant chemotherapy, Brca1 gene, BRCA2 Protein, Chemotherapy, Taxane, business.industry, medicine.disease, 030104 developmental biology, Mutation, Surgery, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d4d02da78d6dfad2d501087b1fc6a39Test
https://u-bourgogne.hal.science/hal-01960320Test

المؤلفون: Janis Gardovskis, Miki Nakazawa-Miklasevica, Inga Melbarde-Gorkusa, Jelena Maksimenko, Arvids Irmejs, Edvins Miklasevics, Genadijs Trofimovics

المصدر: Oncology Letters

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Univariate analysis, education.field_of_study, Multivariate analysis, business.industry, Population, Cancer, Articles, medicine.disease, Bioinformatics, breast cancer, Breast cancer, BRCA1 mutation, Internal medicine, triple-negative breast cancer, Medicine, T-stage, Stage (cooking), business, education, Triple-negative breast cancer

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::336a9e5e9a79b0a27a6c8007992b7536Test
https://doi.org/10.3892/ol.2013.1684Test

المؤلفون: Petra M. Nederlof, A.L.T. Imholz, L. E. van der Kolk, Anne M.M. Oonk, Frans B. L. Hogervorst, Lennart Mulder, Sjoerd Rodenhuis, Jelle Wesseling, Esther H. Lips

المساهمون: Other departments

المصدر: British Journal of Cancer, 108, 10, pp. 2172-7
British journal of cancer, 108(10), 2172-2177. Nature Publishing Group
British Journal of Cancer, 108, 2172-7
British Journal of Cancer

مصطلحات موضوعية: Adult, Oncology, Heterozygote, Cancer Research, medicine.medical_specialty, Pathology, Adolescent, endocrine system diseases, Receptor, ErbB-2, Colorectal cancer, Concordance, DNA Mutational Analysis, Genes, BRCA1, Breast Neoplasms, DCN PAC - Perception action and control, array Comparative Genomic Hybridisation, triple negative, Young Adult, Prostate cancer, breast cancer, Breast cancer, BRCA1 mutation, Internal medicine, BRCAness, Humans, Medicine, skin and connective tissue diseases, Lung cancer, Triple-negative breast cancer, Aged, Cervical cancer, business.industry, Genetics and Genomics, Middle Aged, Prognosis, medicine.disease, Receptors, Estrogen, Female, Skin cancer, Receptors, Progesterone, business, neoadjuvant chemotherapy

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be8c86edb747b87590277457c4216631Test
https://doi.org/10.1038/bjc.2013.144Test

المؤلفون: Constantinidou, Anastasia, Jones, Robin Lewis, Reis-Filho, J. S.

المساهمون: Constantinidou, Anastasia 0000-0001-5316-7574

المصدر: Expert Review of Anticancer Therapy

مصطلحات موضوعية: Systemic therapy, Basal-like, Brca1 mutation, Subtypes, Triple-negative breast cancer

العلاقة: https://gnosis.library.ucy.ac.cy/handle/7/41543Test

الإتاحة: https://doi.org/10.1586/era.10.50Test
https://gnosis.library.ucy.ac.cy/handle/7/41543Test